Indivior Wins Legal Battle; Temporarily Blocks Launch of Generic Drug
June 18 2018 - 3:05AM
Dow Jones News
By Carlo Martuscelli
U.K. pharmaceutical company Indivior PLC (INDV.LN) said Monday
that it has been successful in blocking--for the time being--the
launch of a generic alternative to its Suboxone opioid disorder
medication through the courts.
It said that the U.S. district court of New Jersey had granted
it a restraining order compelling rival drugmaker Dr. Reddy's to
temporarily cease activities related to the development and
marketing of the product.
The order will stay until a hearing can take place on a
preliminary injunction motion filed by Indivior. The company said
it seeks to extend the ban on a launch of a generic Suboxone
alternative.
Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com
(END) Dow Jones Newswires
June 18, 2018 02:50 ET (06:50 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Dr Reddys Laboratories (NYSE:RDY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Dr Reddys Laboratories (NYSE:RDY)
Historical Stock Chart
From Sep 2023 to Sep 2024
